Hyperthyroidism.
McDermott MT.
Ann Intern Med. 2020 Apr 7;172(7):ITC49-ITC64. doi: 10.7326/AITC202004070.
Hyperthyroidism.
Maji D.
J Indian Med Assoc. 2006 Oct;104(10):563-4, 566-7.
Toxic Adenoma in a Patient with Thyroid Hemiagenesis.
Gurleyik E, Dogan S, Cetin F, Gursoy F, Ipor AM.
Cureus. 2017 Sep 17;9(9):e1695. doi: 10.7759/cureus.1695.
Toxic adenoma and papillary thyroid carcinoma in a patient with Graves' disease.
Valenti TM, Macchia E, Pisa R, Bucalo ML, Russo V, Colletti I, Compagno V, Abbadi V, Donatelli M.
J Endocrinol Invest. 1999 Oct;22(9):701-4. doi: 10.1007/BF03343633.
Papillary carcinoma of the thyroid in patients with primary hyperparathyroidism: Is there a link?
Beebeejaun M, Chinnasamy E, Wilson P, Sharma A, Beharry N, Bano G.
Med Hypotheses. 2017 Jun;103:100-104. doi: 10.1016/j.mehy.2017.04.016. Epub 2017 Apr 26.
Effect of drugs on pituitary ultrastructure.
Saeger W.
Microsc Res Tech. 1992 Jan 15;20(2):162-76. doi: 10.1002/jemt.1070200205.
[On the diagnosis of hyperactive thyroid gland adenoma].
FELLINGER K, HOEFER R, EGERT H.
Radiobiol Radiother (Berl). 1962;3:291-6.
MANAGEMENT OF ENDOCRINE DISEASE: Subclinical thyrotoxicosis: prevalence, causes and choice of therapy.
Carlé A, Andersen SL, Boelaert K, Laurberg P.
Eur J Endocrinol. 2017 Jun;176(6):R325-R337. doi: 10.1530/EJE-16-0276. Epub 2017 Mar 8.
Surgical management of a giant parathyroid adenoma through minimal invasive parathyroidectomy. A case report.
Sahsamanis G, Gkouzis K, Samaras S, Pinialidis D, Dimitrakopoulos G.
Int J Surg Case Rep. 2017;31:262-265. doi: 10.1016/j.ijscr.2017.01.064. Epub 2017 Jan 31.
[The role of ultrasonography in thyroid disease].
Gimondo P, Mirk P, Messina G, Pizzi G, Tomei A.
Minerva Med. 1993 Dec;84(12):671-80.
